Identity
- Security key
- 16682
- Ticker
- HURA
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2024-10-18
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- HURA
Detail
Enriched 2026-08-14 20:47
- Market cap
- $149,017,115.52
- Shares outstanding (class)
- 63,682,528
- Shares outstanding (weighted)
- 63,682,528
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 22
- Location
- TAMPA, FL
- Homepage
- https://www.tuhurabio.com
- Description
TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.
Market cap and share counts drift.